For research teamsHelp me find a study
Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 4,129-4,140 of 4,306
Device study icon
CompletedNCT00481026

A Double Blind Sham Controlled study of tDCS in Treating Schizophrenia and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Prahran
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Depression, Schizophrenia
View study
Drug study icon
CompletedNCT00986336

Risperidone and Topiramate Administered Alone and for schizophrenia

This study is completed. It is testing risperidone and Topiramate Administered Alone and for schizophrenia.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
CompletedNCT02161718

ALKS 3831 in Subjects With Schizophrenia and Addiction

This study is completed in the United States, in Bulgaria, and in Poland. It is testing ALKS 3831 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study includes Schizophrenia among several conditions.

Addiction, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Poland
Sponsor
Alkermes, Inc.
Condition
Addiction, Schizophrenia
View study
Drug study icon
CompletedNCT00892125

Safety study of Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in schizophrenia

This study is completed. It is testing Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) for schizophrenia.

Location not clearly listed
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 55 Years
Countries
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition
Bipolarity, Schizophrenia
View study
Drug study icon
TerminatedNCT03643159

A study to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolarity type I, and Major Depressive Disorder

This study was terminated in the United States. It focuses on depression.

Multiple locations, including Santa Rosa
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, Bipolarity, ...DrugFrom 18 Years to 63 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Bipolarity, ...
View study
Behavioral study icon
CompletedNCT04598906

Ecologically Valid Virtual Tasks vs Paper-pencil Methods in Cognitive Rehabilitation in people with Schizophrenia and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Fryštát
Why is this study shown?

This study includes Schizophrenia among several conditions.

Depression, SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
Czechia
Sponsor
National Institute of Mental Health, Czech Republic
Condition
Depression, Schizophrenia
View study
Drug study icon
CompletedNCT00216723

Aripiprazole for schizophrenia

This study is completed in South Korea. It is testing aripiprazole for schizophrenia.

In Seoul
Why is this study shown?

This study includes Schizophrenia among several conditions.

Bipolarity, SchizophreniaDrugFrom 18 Years to 80 Years
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Condition
Bipolarity, Schizophrenia
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.